english

Listes des publications 2019

Hofman P, Dagher G, Laurent-Puig P, Hugo-Marquette C, Barlesi F, Bibeau F, Clément B [Tumor banks and complex data management: Current and future challenges]. Ann Pathol. Feb 25, 2019. doi:10.1016/j.annpat.2019.01.017

Latorzeff I, Bourgier C, Pinel B, Hennequin C, Jimenez G, Chapet O, Zasadny X [Treatment of primary disease (breast, non-small cell lung and prostate cancers) with irradiation in case of de novo metastatic cancer]. Cancer Radiother. Sep 06, 2019. doi:10.1016/j.canrad.2019.08.004

Bourgier C, Latorzeff I, Fenoglietto P, Boisselier P, Charissoux M, Llacer C, Lemanski C, Riou O, Farcy-Jacquet M-P, Azria D [Treatment of oligometastatic or oligoprogression cancer]. Cancer Radiother. Sep 05, 2019. doi:10.1016/j.canrad.2019.07.143

Poinas G, Blache J, Kassab-Chahmi D, Evrard P, Artus P, Alfonsi P, Beaussier M, Cerantola Y, Coloby P, Drapier É, Masson-Lecomt A, Le Normand L, Gamé X, Bosset P, Delaunay L, Fendler J, Ecoffey C, Cuvelier G [Short version of recommendations for enhanced recovery program (ERP) for cystectomy: Technical measures]. Prog. Urol.. 2019;29(2):63-75. doi:10.1016/j.purol.2018.12.002

Poinas G, Blache J, Kassab-Chahmi D, Evrard P, Artus P, Alfonsi P, Beaussier M, Cerantola Y, Coloby P, Drapier É, Masson-Lecomt A, Le Normand L, Gamé X, Bosset P, Delaunay L, Fendler J, Ecoffey C, Cuvelier G [Short version of recommendations for enhanced recovery program (ERP) for cystectomy: Technical measures]. Prog. Urol.. 2019;29(2):63-75. doi:10.1016/j.purol.2018.12.002

Riou O, Bourgier C, Brengues M, Bonnefoi N, Michaud H-A, Castan F, Gourgou S, Draghici R, Farcy-Jacquet M-P, Bons F, Fenoglietto P, Ozsahin M, Azria D [Predictive assays for responses of tumors and normal tissues in radiation oncology]. Cancer Radiother. Aug 23, 2019. doi:10.1016/j.canrad.2019.07.152

Béganton B, Coyaud E, Mangé A, Solassol J [New approaches for protein-protein interaction study]. Med Sci (Paris). 2019;35(3):223-231. doi:10.1051/medsci/2019035

Béganton B, Coyaud E, Mangé A, Solassol J [New approaches for protein-protein interaction study]. Med Sci (Paris). 2019;35(3):223-231. doi:10.1051/medsci/2019035

Pomel C, Lecuru F, Leblanc E, Mathevet P, Colombo P-E, Collinet P, Nadeau C, Huchon C, Chereau E, Lambaudie E, Ferry P, Rafii A, Rouzier R [Minimal invasive surgery for early stage cervical cancer. Recommendations from the GINECO surgeon's group]. Bull Cancer. Jul 25, 2019. doi:10.1016/j.bulcan.2019.05.010

[Management of patients with systemic treatments]. Prog. Urol.. 2019;29 Suppl 1. doi:10.1016/S1166-7087(19)30169-1

Riou O, Valdenaire S, Debuire P, Fenoglietto P, Debrigode C, Mazard T, Assenat É, Azria D [Liver stereotactic body radiotherapy: Clinical features and technical consequences, results. Which treatment machine in which situation?]. Cancer Radiother. Aug 20, 2019. doi:10.1016/j.canrad.2019.07.159

Riou O, Valdenaire S, Debuire P, Fenoglietto P, Debrigode C, Mazard T, Assenat É, Azria D [Liver stereotactic body radiotherapy: Clinical features and technical consequences, results. Which treatment machine in which situation?]. Cancer Radiother. Aug 20, 2019. doi:10.1016/j.canrad.2019.07.159

Bourgier C, Lemanski C, Draghici R, Castan F, Fenoglietto P, Bons F, Farcy-Jacquet M-P, Brengues M, Gourgou S, Ozsahin M, Azria D [Individual modification of the dose, volume and fractionation of breast radiotherapy]. Cancer Radiother. Aug 01, 2019. doi:10.1016/j.canrad.2019.06.004

Pignot G, Houede N [Immunotherapy in urology: Concept and results]. Prog. Urol.. Aug 30, 2019. doi:10.1016/j.purol.2019.08.267

Pourquier P [Genetic and transcriptional evolution alters cancer cell line drug response]. Bull Cancer. 2019;106(1):9-10. doi:10.1016/j.bulcan.2018.12.002

Bakrin N, Classe J, Colombo P, Ferron G, Freyer G, Glehen O, Gouy S, Huchon C, Narducci F, Pocard M, Pomel C, Rouzier R [CHIP and ovarian cancer]. Gynecol Obstet Fertil Senol. Jun 26, 2019. doi:10.1016/j.gofs.2019.06.007

Houédé N, Milano G [Care of advanced or metastatic bladder cancer in second line: A specific place for vinflunine]. Bull Cancer. 2019;106(5):431-435. doi:10.1016/j.bulcan.2019.02.007

Bibeau F [Biomarker, what is the pathologist's role?]. Ann Pathol. 2019;39(3):177-178. doi:10.1016/j.annpat.2019.05.002

Badoual C, Bibeau F [Augmented pathology, future or present ?]. Ann Pathol. Mar 14, 2019. doi:10.1016/j.annpat.2019.02.009

Romanet P, Philibert P, Fina F, Cuny T, Roche C, Ouafik L, Paris F, Reynaud R, Barlier A Using Digital Droplet Polymerase Chain Reaction to Detect the Mosaic GNAS Mutations in Whole Blood DNA or Circulating Cell-Free DNA in Fibrous Dysplasia and McCune-Albright Syndrome. J. Pediatr.. 2019;205. doi:10.1016/j.jpeds.2018.09.070

Mas S, Torro A, Bec N, Erschov G, Gongora C, Larroque C, Martineau P, de Juan A, Marco S Use of physiological information based on grayscale images to improve mass spectrometry imaging data analysis from biological tissues. Anal. Chim. Acta. 2019;1074. doi:10.1016/j.aca.2019.04.074

Mas S, Torro A, Bec N, Erschov G, Gongora C, Larroque C, Martineau P, de Juan A, Marco S Use of physiological information based on grayscale images to improve mass spectrometry imaging data analysis from biological tissues. Anal. Chim. Acta. 2019;1074. doi:10.1016/j.aca.2019.04.074

Mas S, Torro A, Bec N, Erschov G, Gongora C, Larroque C, Martineau P, de Juan A, Marco S Use of physiological information based on grayscale images to improve mass spectrometry imaging data analysis from biological tissues. Anal. Chim. Acta. 2019;1074. doi:10.1016/j.aca.2019.04.074

Vendrell J, Senal R, Rouquette I, Quantin X, Pujol J-L, Bouidioua A, Godreuil S, Coyaud E, Brousset P Ultra-sensitive EGFRT790Mdetection as an independent prognostic marker for lung cancer patients harboring EGFRdel19mutations and treated with first-generation TKIs. Clin. Cancer Res.. Apr 01, 2019. doi:10.1158/1078-0432.CCR-18-2683

D'Hondt V, Canon J-L, Roca L, Levy C, Pierga J-Y, Le Du F, Campone M, Desmoulins I, Goncalves A, Debled M, Rios M, Ferrero J-M, Serin D, Hardy-Bessard A-C, Piot G, Brain E, Dohollou N, Orfeuvre H, Roché H, Delaloge S, Dalenc F UCBG 2-04: Long-term results of the PACS 04 trial evaluating adjuvant epirubicin plus docetaxel in node-positive breast cancer and trastuzumab in the human epidermal growth factor receptor 2-positive subgroup. Eur. J. Cancer. 2019;122. doi:10.1016/j.ejca.2019.09.014

Quénet F, Pissas M-H, Gil H, Roca L, Carrère S, Sgarbura O, Rouanet P, de Forges H, Khellaf L, Deshayes E, Ychou M, Bibeau F Two-stage hepatectomy for colorectal liver metastases: Pathologic response to preoperative chemotherapy is associated with second-stage completion and longer survival. Surgery. 2019;165(4):703-711. doi:10.1016/j.surg.2018.10.006

Quénet F, Pissas M-H, Gil H, Roca L, Carrère S, Sgarbura O, Rouanet P, de Forges H, Khellaf L, Deshayes E, Ychou M, Bibeau F Two-stage hepatectomy for colorectal liver metastases: Pathologic response to preoperative chemotherapy is associated with second-stage completion and longer survival. 2019;165(4):703-711. doi:10.1016/j.surg.2018.10.006

Roux P, Knight S, Cohen M, Classe J, Mazouni C, Chauvet M-P, Reyal F, Colombo P-E, Jouve E, Chopin N, Daraï E, Coutant C, Lambaudie E, Houvenaeghel G Tubular and mucinous breast cancer: results of a cohort of 917 patients. 2019;105(1):55-62. doi:10.1177/0300891618811282

von Minckwitz G, Huang C-S, Mano M, Loibl S, Mamounas E, Untch M, Wolmark N, Rastogi P, Schneeweiss A, Redondo A, Fischer H, Jacot W, Conlin A, Arce-Salinas C, Wapnir I, Jackisch C, DiGiovanna M, Fasching P, Crown J, Wülfing P, Shao Z, Rota Caremoli E, Wu H, Lam L, Tesarowski D, Smitt M, Douthwaite H, Singel S, Geyer C Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer. N. Engl. J. Med.. 2019;380(7):617-628. doi:10.1056/NEJMoa1814017

Costanza B, Rademaker G, Tiamiou A, De Tullio P, Leenders J, Blomme A, Bellier J, Bianchi E, Turtoi A, Delvenne P, Bellahcène A, Peulen O, Castronovo V Transforming growth factor beta-induced, an extracellular matrix interacting protein, enhances glycolysis and promotes pancreatic cancer cell migration. Int. J. Cancer. Mar 04, 2019. doi:10.1002/ijc.32247

Prunaretty J, Boisselier P, Riou O, Simeon S, Bedos L, Azria D, Fenoglietto P Tracking, gating, free-breathing, which technique to use for lung stereotactic treatments? A dosimetric comparison. Rep Pract Oncol Radiother. 2019;24(1):97-104. doi:10.1016/j.rpor.2018.11.003

Prunaretty J, Boisselier P, Riou O, Simeon S, Bedos L, Azria D, Fenoglietto P Tracking, gating, free-breathing, which technique to use for lung stereotactic treatments? A dosimetric comparison. Rep Pract Oncol Radiother. 2019;24(1):97-104. doi:10.1016/j.rpor.2018.11.003

Souche R, Nayeri M, Chati R, Huet E, Donici I, Tuech J, Borie F, Prudhomme M, Jaber S, Fabre J Thoracoscopy in prone position with two-lung ventilation compared to conventional thoracotomy during Ivor Lewis procedure: a multicenter case-control study. Surg Endosc. Mar 13, 2019. doi:10.1007/s00464-019-06742-w

Darlix A, Hirtz C, Thezenas S, Maceski A, Gabelle A, Lopez-Crapez E, Firmin N, Guiu S, Jacot W, Lehmann S The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases. BMC Cancer. 2019;19(1):110. doi:10.1186/s12885-019-5287-z

Darlix A, Hirtz C, Thezenas S, Maceski A, Gabelle A, Lopez-Crapez E, Firmin N, Guiu S, Jacot W, Lehmann S The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases. BMC Cancer. 2019;19(1):110. doi:10.1186/s12885-019-5287-z

Darlix A, Hirtz C, Thezenas S, Maceski A, Gabelle A, Lopez-Crapez E, Firmin N, Guiu S, Jacot W, Lehmann S The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases. 2019;19(1). doi:10.1186/s12885-019-5287-z

Jeschke U, Zhang X, Kuhn C, Colinge J, Pfender K, Mayr D, Ditsch N, Harbeck N, Mahner S, Sixou S The Prognostic Impact of the Aryl Hydrocarbon Receptor (AhR) in Primary Breast Cancer Depends on the Lymph Node Status.. Int J Mol Sci. 2019;20(5). doi:10.3390/ijms20051016

Jeschke U, Zhang X, Kuhn C, Jalaguier S, Colinge J, Pfender K, Mayr D, Ditsch N, Harbeck N, Mahner S, Sixou S, Cavaillès V The Prognostic Impact of the Aryl Hydrocarbon Receptor (AhR) in Primary Breast Cancer Depends on the Lymph Node Status. Int J Mol Sci. 2019;20(5):1016. doi:10.3390/ijms20051016

Saksouk N, Hajdari S, Pratlong M, Barrachina C, Graber C, Zavoriti A, Sarrazin A, Pirot N, Noël J-Y, Khellaf L, Fabbrizio E, Julien E, Cammas F The mouse HP1 proteins are essential for preventing liver tumorigenesis. avril 1, 2019. doi:10.1101/441279

Alame M, Cornillot E, Cacheux V, Tosato G, Four M, Oliveira L, Gofflot S, Delvenne P, Turtoi E, Cabello-Aguilar S, Nishiyama M, Turtoi A, Martineau V, Colinge J The molecular landscape and microenvironment of salivary duct carcinoma reveal new therapeutic opportunities. 2019-10-21. doi:10.1101/810028

Maïmoun L, Mariano-Goulart D, Jaussent A, Lefebvre P, Picot M-C, Mahadea K, Boudousq V, Fouillade C, Nocca D, Fayçal B The effect of excessive fat tissue on the measure of bone mineral density by dual-X ray absorptiometry: the impact of substantial weight loss following sleeve gastrectomy. Clin Physiol Funct Imaging. May 15, 2019. doi:10.1111/cpf.12584

Montero-Luis A, Aristei C, Meattini I, Arenas M, Boersma L, Bourgier C, Coles C, Cutuli B, Falcinelli L, Kaidar-Person O, Leonardi M, Offersen B, Marazzi F, Rivera S, Tagliaferri L, Tombolini V, Vidali C, Valentini V, Poortmans P The Assisi Think Tank Meeting Survey of post-mastectomy radiation therapy in ductal carcinoma in situ: Suggestions for routine practice. Crit. Rev. Oncol. Hematol.. 2019;138. doi:10.1016/j.critrevonc.2019.04.016

Lutz M, Zalcberg J, Ducreux M, Adenis A, Allum W, Aust D, Carneiro F, Grabsch H, Laurent-Puig P, Lordick F, Möhler M, Mönig S, Obermannova R, Piessen G, Riddell A, Röcken C, Roviello F, Schneider P, Seewald S, Smyth E, van Cutsem E, Verheij M, Wagner A, Otto F The 4th St. Gallen EORTC Gastrointestinal Cancer Conference: Controversial issues in the multimodal primary treatment of gastric, junctional and oesophageal adenocarcinoma. Eur. J. Cancer. 2019;112. doi:10.1016/j.ejca.2019.01.106

Daussac A, Barat P, Servant N, Yacoub M, Missonier S, Lavran F, Gaspari L, Sultan C, Paris F Testotoxicosis without Testicular Mass: Revealed by Peripheral Precocious Puberty and Confirmed by Somatic LHCGR Gene Mutation. Endocr. Res.. Aug 08, 2019. doi:10.1080/07435800.2019.1645163

Martineau P, Watier H, Turtoi A Targets for MAbs: innovative approaches for their discovery & validation, LabEx MAbImprove 6th antibody industrial symposium, June 25-26, 2018, Montpellier, France. MAbs. May 01, 2019. doi:10.1080/19420862.2019.1612691

Martineau P, Watier H, Turtoi A Targets for MAbs: innovative approaches for their discovery & validation, LabEx MAbImprove 6th antibody industrial symposium, June 25-26, 2018, Montpellier, France. MAbs. May 01, 2019. doi:10.1080/19420862.2019.1612691

Chartron E, Theillet C, Guiu S, Jacot W Targeting homologous repair deficiency in breast and ovarian cancers: Biological pathways, preclinical and clinical data. Crit. Rev. Oncol. Hematol.. 2019;133. doi:10.1016/j.critrevonc.2018.10.012

Chartron E, Theillet C, Guiu S, Jacot W Targeting homologous repair deficiency in breast and ovarian cancers: Biological pathways, preclinical and clinical data. Crit. Rev. Oncol. Hematol.. 2019;133. doi:10.1016/j.critrevonc.2018.10.012

Chauvin D, Hust M, Schütte M, Chesnay A, Parent C, Moreira G, Arroyo J, Sanz A, Pugnière M, Martineau P, Chandenier J, Heuzé-Vourc'h N, Desoubeaux G Targeting Aspergillus fumigatus Crf Transglycosylases With Neutralizing Antibody Is Relevant but Not Sufficient to Erase Fungal Burden in a Neutropenic Rat Model. Front Microbiol. 2019;10. doi:10.3389/fmicb.2019.00600

Champagne J, Linares L, Maurel B, Zampieri A, Moreno M, Fuentes I, Dubois E, Severac D, Decorsière A, Bienvenu F TAG-RNAi overcomes off-target effects in cancer models. Oncogene. Sep 26, 2019. doi:10.1038/s41388-019-1020-2

Tümmler C, Dumitriu G, Wickström M, Coopman P, Valkov A, Kogner P, Johnsen J, Moens U, Sveinbjörnsson B SYK Inhibition Potentiates the Effect of Chemotherapeutic Drugs on Neuroblastoma Cells in Vitro. Cancers (Basel). 2019;11(2). doi:10.3390/cancers11020202

Pons-Tostivint E, Kirova Y, Campone M, Geffrelot J, Mazouni C, Mailliez A, Pasquier D, Madranges N, Firmin N, Crouzet A, Jankowski C, De La Motte Rouge T, Pouget N, de La Lande B, Mouttet-Boizat D, Ferrero J-M, Uwer L, Eymard J-C, Mouret-Reynier M-A, Petit T, Robain M, Filleron T, Cailliot C, Dalenc F Survival Impact of Locoregional Treatment of the Primary Tumor in De Novo Metastatic Breast Cancers in a Large Multicentric Cohort Study: A Propensity Score-Matched Analysis. 2019;26(2):356-365. doi:10.1245/s10434-018-6831-9

Blay J-Y, Honoré C, Stoeckle E, Jafari M, Gouin F, Anract P, Ferron G, Rochwerger A, Ropars M, Carrere S, Marchal F, Sirveaux F, Di Marco A, Le Nail L, Guiramand J, Vaz G, Machiavello J-C, Marco O, Causeret S, Gimbergues P, Fiorenza F, Chaigneau L, Guillemin F, Guilloit J-M, Dujardin F, Spano J-P, Ruzic J-C, Michot A, Soibinet P, Bompas E, Chevreau C, Duffaud F, Rios M, Perrin C, Firmin N, Bertucci F, Le Loarer F, Collard O, Karanian-Philippe M, Brahmi M, Dufresne A, Dupré A, Ducimetière F, Giraud A, Pérol D, Toulmonde M, Ray-Coquard I, Italiano A, Le Cesne A, Penel N, Bonvalot S Surgery in reference centers improves survival of sarcoma patients: a nationwide study. Ann. Oncol.. 06 05, 2019. doi:10.1093/annonc/mdz170

Blay J-Y, Honoré C, Stoeckle E, Jafari M, Gouin F, Anract P, Ferron G, Rochwerger A, Ropars M, Carrere S, Marchal F, Sirveaux F, Di Marco A, Le Nail L, Guiramand J, Vaz G, Machiavello J-C, Marco O, Causeret S, Gimbergues P, Fiorenza F, Chaigneau L, Guillemin F, Guilloit J-M, Dujardin F, Spano J-P, Ruzic J-C, Michot A, Soibinet P, Bompas E, Chevreau C, Duffaud F, Rios M, Perrin C, Firmin N, Bertucci F, Le Loarer F, Collard O, Karanian-Philippe M, Brahmi M, Dufresne A, Dupré A, Ducimetière F, Giraud A, Pérol D, Toulmonde M, Ray-Coquard I, Italiano A, Le Cesne A, Penel N, Bonvalot S Surgery in reference centers improves survival of sarcoma patients: a nationwide study. Ann. Oncol.. 06 05, 2019. doi:10.1093/annonc/mdz170

Harsini F, Bui A, Rice A, Chebrolu S, Fuson K, Turtoi A, Bradberry M, Chapman E, Sutton R Structural Basis for the Distinct Membrane Binding Activity of the Homologous C2A Domains of Myoferlin and Dysferlin. J. Mol. Biol.. 2019;431(11):2112-2126. doi:10.1016/j.jmb.2019.04.006

Assenat E, Pageaux G-P, Peron J-M, Bécouarn Y, Seitz J-F, Merle P, Blanc J-F, Bouché O, Ramdani M, Poujol S, de Forges H, Ychou M, Boige V Sorafenib alone vs. sorafenib plus GEMOX as 1st-line treatment for advanced HCC: the phase II randomised PRODIGE 10 trial. Br. J. Cancer. Apr 04, 2019. doi:10.1038/s41416-019-0443-4

Kalfa N, Amouroux C, Fuchs F Should We Really Screen for Genital Variants Before Birth?. Eur. Urol.. 2019;S0302-2838(19):30353-7. doi:10.1016/j.eururo.2019.04.037

Carayol M, Ninot G, Senesse P, Bleuse J-P, Gourgou S, Sancho-Garnier H, Sari C, Romieu I, Romieu G, Jacot W Short- and long-term impact of adapted physical activity and diet counseling during adjuvant breast cancer therapy: the "APAD1" randomized controlled trial. BMC Cancer. 2019;19(1):737. doi:10.1186/s12885-019-5896-6

Flippot R, Dalban C, Laguerre B, Borchiellini D, Négrier S, Chevreau C, Joly F, Geoffrois L, Ladoire S, Mahammedi H, Gross-Goupil M, Deluche E, Priou F, Laramas M, Barthélémy P, Narciso B, Oudard S, Chenot M, Tantot F, Chabaud S, Escudier B, Albiges L Safety and Efficacy of Nivolumab in Brain Metastases From Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study. J. Clin. Oncol.. 2019;37(23):2008-2016. doi:10.1200/JCO.18.02218

Carrier G, Rouanet P, Colombo P Robotic colon resection for splenic flexure cancer with intracorporeal anastomosis (with video). J Visc Surg. Jul 16, 2019. doi:10.1016/j.jviscsurg.2019.06.013

Amestoy F, Roubaud G, Antoine M, Fonteyne V, Baumann B, Christodouleas J, Azria D, Zilli T, Hennequin C, Xylinas E, Sargos P Review of hypo-fractionated radiotherapy for localized muscle invasive bladder cancer. Crit. Rev. Oncol. Hematol.. 2019;142. doi:10.1016/j.critrevonc.2019.06.010

Kalmanovich E, Roubille F, Castet-Nicolas A Response to 'Pharmacy-based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM-CHF randomized controlled trial'. Eur. J. Heart Fail.. Sep 09, 2019. doi:10.1002/ejhf.1602

Seibold P, Webb A, Aguado-Barrera M, Azria D, Brengues M, Briers E, Bultijnck R, Calvo-Crespo P, Carballo A, Choudhury A, Cicchetti A, Claßen J, Delmastro E, Dunning A, Elliott R, Farcy-Jacquet M-P, Gabriele P, Garibaldi E, Gómez-Caamaño A, Gutiérrez-Enríquez S, Higginson D, Johnson K, Lobato-Busto R, Mollà M, Müller A, Payne D, Peleteiro P, Post G, Rancati T, Rattay T, Reyes V, Rosenstein B, De Ruysscher D, De Santis M, Schäfer J, Schnabel T, Sperk E, Symonds R, Stobart H, Taboada-Valladares B, Talbot C, Valdagni R, Vega A, Veldeman L, Ward T, Weißenberger C, West C, Chang-Claude J REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer. Radiother Oncol. 2019;138. doi:10.1016/j.radonc.2019.04.034

Mercier F, Dagbert F, Pocard M, Goéré D, Quenet F, Wernert R, Dumont F, Brigand C, Passot G, Glehen O Recurrence of pseudomyxoma peritonei after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. BJS Open. 2019;3(2):195-202. doi:10.1002/bjs5.97

Nougaret S, Jhaveri K, Kassam Z, Lall C, Kim D Rectal cancer MR staging: pearls and pitfalls at baseline examination. Abdom Radiol (NY). May 21, 2019. doi:10.1007/s00261-019-02024-0

Hope T, Gollub M, Arya S, Bates D, Ganeshan D, Harisinghani M, Jhaveri K, Kassam Z, Kim D, Korngold E, Lalwani N, Moreno C, Nougaret S, Paroder V, Paspulati R, Golia Pernicka J, Petkovska I, Pickhardt P, Rauch G, Rosenthal M, Sheedy S, Horvat N Rectal cancer lexicon: consensus statement from the society of abdominal radiology rectal & anal cancer disease-focused panel. Abdom Radiol (NY). Aug 06, 2019. doi:10.1007/s00261-019-02170-5

Otandault A, Anker P, Al Amir Dache Z, Guillaumon V, Meddeb R, Pastor B, Pisareva E, Sanchez C, Tanos R, Tousch G, Schwarzenbach H, Thierry A Recent advances in Circulating Nucleic Acids in oncology. Ann. Oncol.. Feb 07, 2019. doi:10.1093/annonc/mdz031

Jacot W, Heudel P-E, Fraisse J, Gourgou S, Guiu S, Dalenc F, Pistilli B, Campone M, Levy C, Debled M, Leheurteur M, Chaix M, Lefeuvre C, Goncalves A, Uwer L, Ferrero J-M, Eymard J-C, Petit T, Mouret-Reynier M-A, Courtinard C, Cottu P, Robain M, Mailliez A Real-life activity of eribulin mesylate among metastatic breast cancer patients in the multicenter national observational ESME program. Int. J. Cancer. May 14, 2019. doi:10.1002/ijc.32402

Jacot W, Heudel P-E, Fraisse J, Gourgou S, Guiu S, Dalenc F, Pistilli B, Campone M, Levy C, Debled M, Leheurteur M, Chaix M, Lefeuvre C, Goncalves A, Uwer L, Ferrero J-M, Eymard J-C, Petit T, Mouret-Reynier M-A, Courtinard C, Cottu P, Robain M, Mailliez A Real-life activity of eribulin mesylate among metastatic breast cancer patients in the multicenter national observational ESME program. Int. J. Cancer. May 14, 2019. doi:10.1002/ijc.32402

Tetreau R, Honoré C, Tzanis D, Delhorme J-B, Fau M, Decanter G, Llacer C, Firmin N, Stoeckle E, Ferron G, Cupissol D, Meunier B, Bonvalot S Quelle prise en charge optimale pour un sarcome du cordon spermatique en 2018 ?. 2019;29(1):12-17. doi:10.1016/j.purol.2018.09.010

Lacombe J, Brengues M, Mangé A, Bourgier C, Gourgou S, Pèlegrin A, Ozsahin M, Solassol J, Azria D Quantitative proteomic analysis reveals AK2 as potential biomarker for late normal tissue radiotoxicity. Radiat Oncol. 2019;14(1):142. doi:10.1186/s13014-019-1351-8

Lacombe J, Brengues M, Mangé A, Bourgier C, Gourgou S, Pèlegrin A, Ozsahin M, Solassol J, Azria D Quantitative proteomic analysis reveals AK2 as potential biomarker for late normal tissue radiotoxicity. Radiat Oncol. 2019;14(1):142. doi:10.1186/s13014-019-1351-8

Mazard T, Assenat E, Dupuy M, Mollevi C, René A, Adenis A, Chauffert B, Boucher E, Francois E, Pierga J-Y, Ducreux M, Ychou M, Gallix B Quantitative evaluation of liver metastases density on computed tomography: A new tool to evaluate early response to bevacizumab-containing chemotherapy. Dig Liver Dis. May 10, 2019. doi:10.1016/j.dld.2019.03.028

Meddeb R, Dache Z, Thezenas S, Otandault A, Tanos R, Pastor B, Sanchez C, Azzi J, Tousch G, Azan S, Mollevi C, Adenis A, El Messaoudi S, Blache P, Thierry A Quantifying circulating cell-free DNA in humans. Sci Rep. 2019;9(1):5220. doi:10.1038/s41598-019-41593-4

Alegre N, Perre P, Bignon Y, Michel A, Galibert V, Mophawe O, Corsini C, Coupier I, Chiesa J, Robert L, Bernhard L, Picot M-C, Bertet H, Macioce V, Bastide N, Solassol J, Rey J, Thomas F, Carton S, Pujol P Psychosocial and clinical factors of probands impacting intrafamilial disclosure and uptake of genetic testing among families with BRCA1/2 or MMR gene mutations. Psychooncology. Jun 01, 2019. doi:10.1002/pon.5142

Béganton B, Solassol I, Mangé A, Solassol J Protein interactions study through proximity-labeling. Expert Rev Proteomics. Jul 04, 2019. doi:10.1080/14789450.2019.1638769

Bec N, Bonhoure A, Henry L, Berry L, Larroque C, Coux O, Stoebner P-E, Vidal M Proteasome 19S RP and translation preinitiation complexes are secreted within exosomes upon serum starvation. Traffic. May 01, 2019. doi:10.1111/tra.12653

Müller K, Sixou S, Kuhn C, Mayr D, Ditsch N, Weissenbacher T, Harbeck N, Mahner S, Cavaillès V, Jeschke U Prognostic relevance of RIP140 and ER? expression in unifocal versus multifocal breast cancers: a preliminary report. Int J Mol Sci. 2019;20(2):418. doi:10.3390/ijms20020418

Hollande L, Do Marcolino I, Balaguer P, Domenek S, Gross R, Allais F Preparation of Renewable Epoxy-Amine Resins With Tunable Thermo-Mechanical Properties, Wettability and Degradation Abilities From Lignocellulose- and Plant Oils-Derived Components. Front Chem. 2019;7. doi:10.3389/fchem.2019.00159

Fuchs F, Borrego P, Amouroux C, Antoine B, Ollivier M, Faure J-M, Lopez C, Forgues D, Faure A, Merrot T, Boulot P, Jeandel C, Philibert P, Gaspari L, Sultan C, Paris F, Kalfa N Prenatal imaging of genital defects: clinical spectrum and predictive factors for severe forms. BJU Int.. Feb 18, 2019. doi:10.1111/bju.14714

Angeles M, Vieille P, Gladieff L, Ruiz J, Picard M, Migliorelli F, Martínez-Gómez C, Martinez A Predictive risk factors of acute kidney injury after cytoreductive surgery and cisplatin-based hyperthermic intra-peritoneal chemotherapy for ovarian peritoneal carcinomatosis. Int. J. Gynecol. Cancer. Jan 23, 2019. doi:10.1136/ijgc-2018-000099

Auperin A, Rivera S, Boisselier P, Lang P, Lassau N, Taourel P, Azria D, Bourhis J, Deutsch E, Vozenin M-C Pravastatin Reverses Established Radiation-Induced Cutaneous and Subcutaneous Fibrosis in Patients With Head and Neck Cancer: Results of the Biology-Driven Phase 2 Clinical Trial Pravacur. Int. J. Radiat. Oncol. Biol. Phys.. 2019;104(2):365-373. doi:10.1016/j.ijrobp.2019.02.024

Broudic-Guibert M, Blay J-Y, Vazquez L, Evrard A, Karanian M, Taïeb S, Hoog-Labouret N, Oukhatar C, Boustany-Grenier R, Arnaud A Persistent response to vemurafenib in metastatic ameloblastoma with BRAF mutation: a case report. J Med Case Rep. 2019;13(1):245. doi:10.1186/s13256-019-2140-6

Panaro F, Giannone F, Sgarbura O, Cusumano C, Deshayes E, Navarro F, Guiu B Perioperative impact of liver venous deprivation compared with portal venous embolization in patients undergoing right hepatectomy: preliminary results from the pioneer center. Hepatobiliary Surg Nutr. 2019;8(4):329-337. doi:10.21037/hbsn.2019.07.06

Panaro F, Giannone F, Sgarbura O, Cusumano C, Deshayes E, Navarro F, Guiu B Perioperative impact of liver venous deprivation compared with portal venous embolization in patients undergoing right hepatectomy: preliminary results from the pioneer center. Hepatobiliary Surg Nutr. 2019;8(4):329-337. doi:10.21037/hbsn.2019.07.06

Sgarbura O, Hübner M, Alyami M, Eveno C, Gagnière J, Pache B, Pocard M, Bakrin N, Quénet F Oxaliplatin use in pressurized intraperitoneal aerosol chemotherapy (PIPAC) is safe and effective: A multicenter study. Eur J Surg Oncol. May 09, 2019. doi:10.1016/j.ejso.2019.05.007

Bianco J, Bergoglio V, Lin Y-L, Pillaire M-J, Schmitz A-L, Gilhodes J, Lusque A, Mazières J, Lacroix-Triki M, Roumeliotis T, Choudhary J, Moreaux J, Hoffmann J-S, Tourrière H, Pasero P Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner. Nat Commun. 2019;10(1):910. doi:10.1038/s41467-019-08886-8

Souche R, Coignac A, Dupuy M, Bertrand M, Raingeart I, Guiu B, Herrero A, Panaro F, Portales F, Ramos J, Colombo P-E, Prudhomme M, Assenat E, Fabre J-M Outcome after pancreatectomy for neuroendocrine neoplams according to the WHO 2017 grading system: A retrospective multicentric analysis of 138 consecutive patients. Clin Res Hepatol Gastroenterol. Sep 19, 2019. doi:10.1016/j.clinre.2019.08.010

Cabel L, Carton M, Cheaib B, Pierga J-Y, Dalenc F, Mailliez A, Levy C, Jacot W, Debled M, Leheurteur M, Desmoulins I, Lefeuvre C, Uwer L, Ferrero J-M, Eymard J-C, Petit T, Mouret-Reynier M-A, Perrocheau G, Piot I, Pérol D, Simon G, Lerebours F Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimens. Breast Cancer Res. Treat.. 2019;173(2):397-406. doi:10.1007/s10549-018-5017-2

Soyer-Gobillard M-O, Gaspari L, Courtet P, Puillandre M, Paris F, Sultan C Neurodevelopmental disorders in children exposed in utero to synthetic progestins: analysis from the national cohort of the Hhorages Association. Gynecol. Endocrinol.. 2019;35(3):247-250. doi:10.1080/09513590.2018.1512968

Buffard M, Naldi A, Radulescu O, Coopman P, Larive R, Freiss G Network reconstruction and Significant Pathway Extraction Using Phosphoproteomic Data From Cancer Cells. Proteomics. Aug 31, 2019. doi:10.1002/pmic.201800450

Boutanos C, Capdepont M, Svrcek M, Thélu F, Guedj N, Poizat F, Bibeau F, Turlin B, Rousseau A, Bardier A, Selves J, Desrousseaux M, Le Pessot F, Bonhomme B, Laverrière M-H, Julié C, Eyremandi R-P, Stanislas S, Bazille C, Daubech A, Lazure T, Bordier M-S, Demoures A, Rullier A National multicentric evaluation of quality of pathology reports for rectal cancer in France in 2016. Virchows Arch.. 2019;474(5):561-568. doi:10.1007/s00428-019-02534-8

Hofman V, Rouquette I, Long-Mira E, Piton N, Chamorey E, Heeke S, Vignaud J, Yguel C, Mazières J, Lepage A-L, Bibeau F, Begueret H, Lassalle S, Lalvée S, Zahaf K, Benzaquen J, Poudenx M, Marquette C-H, Sabourin J-C, Ilié M, Hofman P Multicenter evaluation of a novel ROS1 immunohistochemistry assay (SP384) for detection of ROS1 rearrangements in a large cohort of lung adenocarcinoma patients. J Thorac Oncol. Apr 15, 2019. doi:10.1016/j.jtho.2019.03.024

Talbot C, Veldwijk M, Azria D, Batini C, Bierbaum M, Brengues M, Chang-Claude J, Johnson K, Keller A, Smith S, Sperk E, Symonds R, Wenz F, West C, Herskind C Multi-centre technical evaluation of the radiation-induced lymphocyte apoptosis assay as a predictive test for radiotherapy toxicity. Clin Transl Radiat Oncol. 2019;18. doi:10.1016/j.ctro.2019.06.001

Kalfa N, Gaspari L, Ollivier M, Philibert P, Bergougnoux A, Sultan C Molecular genetics of hypospadias and cryptorchidism recent developments. Clin. Genet.. 2019;95(1):122-131.

Bonnefoi H, MacGrogan G, Poncet C, Iggo R, Pommeret F, Grellety T, Larsimont D, Bécette V, Kerdraon O, Bibeau F, Ghnassia J-P, Picquenot J-M, Thomas J, Tille J-C, Slaets L, Bodmer A, Bergh J, Cameron D Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes. Br. J. Cancer. Mar 22, 2019. doi:10.1038/s41416-019-0420-y

Dupasquier S, Blache P, Picque Lasorsa L, Zhao H, Abraham J-D, Haigh J, Ychou M, Prévostel C Modulating PKC? Activity to Target Wnt/?-Catenin Signaling in Colon Cancer. Cancers (Basel). 2019;11(5). doi:10.3390/cancers11050693

van Hilst J, de Rooij T, Klompmaker S, Rawashdeh M, Aleotti F, Al-Sarireh B, Alseidi A, Ateeb Z, Balzano G, Berrevoet F, Björnsson B, Boggi U, Busch O, Butturini G, Casadei R, Del Chiaro M, Chikhladze S, Cipriani F, van Dam R, Damoli I, van Dieren S, Dokmak S, Edwin B, van Eijck C, Fabre J-M, Falconi M, Farges O, Fernández-Cruz L, Forgione A, Frigerio I, Fuks D, Gavazzi F, Gayet B, Giardino A, Groot Koerkamp B, Hackert T, Hassenpflug M, Kabir I, Keck T, Khatkov I, Kusar M, Lombardo C, Marchegiani G, Marshall R, Menon K, Montorsi M, Orville M, de Pastena M, Pietrabissa A, Poves I, Primrose J, Pugliese R, Ricci C, Roberts K, Røsok B, Sahakyan M, Sánchez-Cabús S, Sandström P, Scovel L, Solaini L, Soonawalla Z, Souche F, Sutcliffe R, Tiberio G, Tomazic A, Troisi R, Wellner U, White S, Wittel U, Zerbi A, Bassi C, Besselink M, Abu Hilal M Minimally Invasive versus Open Distal Pancreatectomy for Ductal Adenocarcinoma (DIPLOMA): A Pan-European Propensity Score Matched Study. Ann. Surg.. 2019;269(1):10-17. doi:10.1097/SLA.0000000000002561

Larbouret C, Poul M-A, Chardès T Mimicking polyclonal immune response in therapy: from combination of two monoclonal antibodies to oligoclonal antibody-based mixtures. 2019;in press.

Nokin M-J, Bellier J, Durieux F, Peulen O, Rademaker G, Gabriel M, Monseur C, Charloteaux B, Verbeke L, van Laere S, Roncarati P, Herfs M, Lambert C, Scheijen J, Schalkwijk C, Colige A, Caers J, Delvenne P, Turtoi A, Castronovo V, Bellahcène A Methylglyoxal, a glycolysis metabolite, triggers metastasis through MEK/ERK/SMAD1 pathway activation in breast cancer. Breast Cancer Res.. 2019;21(1):11. doi:10.1186/s13058-018-1095-7


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés